Summary. Embryos were collected from superovulated ewes on Day 2 (2\p=n-\8cell), Day 4 (8\p=n-\16cell) and Day 6 (morula/early blastocyst). Two embryos were cultured in 1 ml of one of four media: (i) Ham 
Introduction
Pre-implantation mice (O'Neill, 1985; Collier et ai, 1988; Ryan et ai, 1989) and human (Collier et al, 1988 (Collier et al, , 1990 embryos secrete an ether phospholipid which is homologous with plateletactivating factor (PAF, l-o-alkyl-2-acetyl-sn-glyceryl-3-phosphocholine). The amount of PAF produced by human embryos was positively correlated with their pregnancy potential after transfer (O'Neill, 1987) . Embryo-derived PAF appears to have an autocrine role, since (i) there is a direct, specific influence of exogenous PAF in vitro on the oxidative metabolism of energy substrates (glucose and lactate) by mouse embryos (Ryan et al., , 1990a , (ii) supplementation of culture media with PAF in which 2-cell mouse embryos were cultured for 72 h increased the number of cells in the expanded blastocysts, (iii) similar supplementation of media significantly increased the implantation rate and pregnancy potential of both mouse (Ryan et al., 1990b) and human (O'Neill et ai, 1989) embryos and (iv) treatment of mouse embryos with PAF inhibitors prevented blasto¬ cyst outgrowth in vitro (Spinks et al., 1990) and the ability of embryos to implant in vivo (Spinks & O'Neill, 1988; Spinks et al., 1990) . PAF may also exert effects on maternal physiology as evidenced by mild, but significant, thrombocytopenia in some species (mouse, O'Neill, 1985; cow, Hansel, 1988) , the attenuation of oxytocin-induced prostaglandin (PG) F-2a release from the ovine uterus in vivo (Battye et al., 1989) , and the modification of prostaglandin secretion by human (Smith & Kelly, 1988) and bovine (Gross et al., 1990) Embryo-derived PAF was removed from the TLC plate by scraping the area corresponding to the R, of synthetic PAF (R, = 0-22 ± 001, = 32) and eluted with 2 ml of chloroform: methanol: water (1:2:0-8, v/v). Following centri¬ fugation (1500 g for 10 min), the solvent was removed to a clean tube. Chloroform (0-5 ml) and water (0-5 ml) were added to effect phase separation. The lower chloroform phase was washed once with 1 ml of methanol: water (10:9, v/v). For all extractions of embryo culture medium, a control blank was also extracted. The control blank was the same medium, but had not been exposed to embryos. The PAF concentrations measured in the control blanks were subtracted from the unknown sample PAF determinations after both had been corrected for [3H]PAF recovery.
PAF bioassay. The embryo-derived PAF was measured using a sensitive rabbit platelet bioassay (Collier et ai, 1988) . The concentration of PAF was related directly to the degree of platelet aggregation induced in a sample of whole blood in the presence of citrate anticoagulant, an ADP scavenger (phospho(enol) ai, 1986) to confirm that the platelet aggregation induced by embryo culture media extract was due to PAF. The detection limit of the bioassay was 5-6 nM (3 ng/ml) (Collier et ai, 1990) .
A culture was defined as PAF positive if the PAF concentration was greater than the mean + 1 -96 standard deviations of the specific control blanks.
Comparison of PAF bioassay and PAF-specific radioimmunoassay. There was insufficient sample left after bioassay to test each sample individually with the radioimmunoassay (RIA). Therefore, samples of embryo-derived PAF in PBS-BSA which showed similar concentration in the bioassay were pooled. Very low (below the sensitivity of the bioassay), low (ll-37nM), medium (43-112 nM) and high (141-366 nM) extracted samples of embryo-derived PAF were pooled and assayed using a radioimmunoassay for PAF (NEN Du Pont, NEK-062). The PAF-RIA was per¬ formed according to the manufacturer's instructions. The PAF-RIA kit uses PAF-specific antibodies raised in sheep. The labelled PAF-antibody complex was precipitated by a second antibody and the radioactivity in the precipitate was measured. The amount of labelled PAF in the precipitate is inversely proportional to the amount of PAF in the solution being assayed. The sheep anti-PAF antibody used in the RIA is highly specific for PAF (Smal et ai, 1990) . The sensitivity of the RIA was 0-56 nM (0-30 ng/ml) and the interassay coefficient of variation was 5-3%.
As 
PAF concentration in culture media
Low concentrations of PAF were measured consistently in culture media not exposed to embryos (control blanks), and were higher in SOFM 4-HS than in the three other media (P < 0-01, Table 2 ). The PAF activity was inhibited when tested in the presence of the PAFreceptor antagonist, SRI 63-441, suggesting that it was PAF, but not PAF derived from embryos.
There was wide variation in the concentration of PAF measured in culture medium in which sheep embryos had been grown for 24 h (0-411 nM, i.e. 0-205 pmol/embryo/24 h). Overall, 21/95 (221%) cultures were PAF-positive (Table 3 ). There was no significant effect of culture medium used, or the developmental stage of the embryo, on the proportion of cultures that were positive for Values with different superscripts are significantly different at (P < 005). (Table   4 ). The amount of PAF produced by embryos was not affected by the stage of development (Table  4) . Therefore, when the data were pooled, the average amount of PAF produced by embryos in the PAF-positive cultures was 60-9 + 9-8 pmol/embryo/24 h.
Overall Comparison of bioassay and radioimmunoassay Pooled samples of embryo-derived PAF (previously bioassayed) were measured by the PAF-RIA. There was agreement between the two assay systems in ranking of concentrations of the samples, i.e. low, medium and high, the RIA having greater sensitivity than the bioassay and giving 1-5-3-5 times higher values. Because of the limited amount of material available for this retrospective analysis, a direct comparison of the bioassay and the RIA was not possible.
Structural study
The acetyl group from the C2 position is essential for biological activity of PAF, and is removed by PLA2 (Benveniste et al., 1977) . Pretreatment of synthetic and embryo-derived PAF (41 nM) with 30 iu/ml PLA2 (measured in duplicate), reduced the platelet-aggregating activity of both to a similar extent (Fig. 1) . Only single measurements were made at PLA2 concentrations of 7-5 and 15 iu/ml, because of a lack of sample, but, at each of these concentrations, the bioactivities of synthetic PAF and embryo-derived PAF were similar. (Smal et al., 1989 Cooney et al., 1990) . The detection of putative embryo-derived PAF by the radioimmuno¬ assay offers further support for structural homology between ovine embryo-derived PAF and l-o-alkyl-2-acetyl-sn-glyceryl-3-phosphocholine. The deactivation of sheep embryo-derived PAF by PLA2 confirms that the PAF produced by sheep embryos is homologous with that produced by mouse and human embryos (Collier et al., 1988) . PAF was produced by sheep embryos at the three developmental stages examined (2-8 cell, [8] [9] [10] [11] [12] [13] [14] [15] [16] cell, morula/early blastocyst) (Tables 3 and 4) . PAF production by mouse embryos at these stages has been reported (Collier et al., 1988; , and by human embryos at the 1^1 cell stage (Collier et al., 1988 (Collier et al., , 1990 . In this study, no difference was observed between the three developmental stages on the proportion of cultures which were PAF-positive. However, the numbers of positive cultures on Days 2 and 4 were low.
Discussion
It has been suggested that PAF production by embryos may serve as a marker for embryo viability and pregnancy potential (O'Neill, 1987) . Collier et al. (1990) (Collier et al., 1990) . PAF activity was measured consistently in control media blanks in this study, but was highest in SOFM + HS. The apparent low 'PAF-like' activity was observed in both the bioassay and RIA. The extraction procedure and/or addition of [3H]PAF to culture media may have con¬ tributed to the low levels measured. The presence of PAF in human and rat serum has been reported (Caramelo et al., 1984) (Collier et al., 1990) .
It has been shown that early stage sheep embryos produce the ether phospholipid PAF. The mean amount of PAF produced by sheep embryos (60-9 + 9-8 pmol/embryo/24 h) was comparable to that reported for human (range 9-717 pmol/embryo/24 h) and mouse (1-5-31-0 pmol/embryo/ 24 h) embryos (Collier et al., 1988) . The four culture media used in this study supported the production of PAF by some sheep embryos to a similar extent. It was shown previously that culture in vitro compromised the capacity of mouse embryos to secrete PAF (Ryan et ai, 1989) , but that the addition of exogenous PAF could apparently compensate for this, resulting in enhanced metabolism and viability for both human and mouse embryos (Ryan et al., 1990a, b 
